Prototype of portable, battery powered, biosensing device - a few centimetres in size.<\/p>\n
Archer Materials has announced progressing work on its graphene-based biosensor technology.<\/p>\n
The Australian company told shareholders on Thursday it has developed a new set of graphene materials that could be applied for enhanced biosensing and to aid in the development of biocompatible inks in water-based solvents.<\/p>\n
Archer said doing so could eliminate the use of hazardous and non-biocompatible chemicals, increasing the scope of biomolecules that can be detected.<\/p>\n
\"There is no doubt that diseases have a devastating effect on economies and there is value in advancing disease diagnosis using simpler, more accurate biosensors,\" Archer CEO Dr Mohammad Choucair said. \"However, there are only a limited number of materials that can perform [biosensing], and they require innovative development.\"<\/p>\n
Archer said laboratory synthesis was complemented with computational chemistry to calculate and visualise the materials candidates at the atom-level for their suitability in biomolecular sensing.<\/p>\n
\"We have rapidly advanced from raw material feedstock to prototypes of a portable battery-powered sensing device that can incorporate biological material,\" Choucair said. \"This early stage work has the potential to allow much simpler and more effective sensing where early diagnosis of life-threatening diseases can lead to much improved outcomes.\" <\/p>\n
With Australia traditionally not so good at commercialising research and development, Archer touted its graphene-based biotechnology as at an early stage of commercialisation. <\/p>\n
It said it has been working with commercial advisors within the Australian biotech industry to produce a roadmap. <\/p>\n
Archer's commercial strategy involves applying the \"triple-helix business model\" for biotechnology innovation to develop printable graphene-based biosensor componentry and sublicense the associated intellectual property rights.<\/p>\n
It's hoping to do this by developing commercial-grade prototypes; pursuing patent applications in Australia, the United States, and Europe; and establishingcommercial partnerships.<\/p>\n
Last month, Archer announced its plan to raise up to AU$3 million, offering shares at AU$0.60 per share. <\/p>\n
The funds raised will be used to increase the pace of Archer's current work programs and to start hiring additional staff to do this work, it said.<\/p>\n
Also in May, Archer announced a new agreement with IBM which it hopes will advance quantum computing and progress work towards solutions for the greater adoption of the technology.<\/p>\n
Joining theIBM Q Network, Archer will gain access to IBM's quantum computing expertise and resources, seeing the Sydney-based company use IBM's open-source software framework, Qiskit.<\/p>\n
Archer to work alongside IBM in progressing quantum computing<\/p>\n
First quantum-focused Australian member of the IBM Q Network.<\/p>\n
Archer puts together a few-qubit array<\/p>\n
The Australian company has taken the next step towards creating a room temperature quantum computer.<\/p>\n
Australia's Archer details first stage of room temp quantum chip success<\/p>\n
The company has announced assembly of the first qubit material component of its 12CQ room-temperature qubit processor, touting nanometre precision.<\/p>\n
<\/p>\n